Reducing the CAV1-dependent trafficking of G6PC1 in the liver protects against the development of type 2 diabetes
Da Costa, L.; Saint-Beat, C.; Bron, C.; Lang, A.; Duchampt, A.; Micoud, M.; Evrard, F.; Mithieux, G.; Stein, A. G.
Show abstract
Targeting hepatic gluconeogenesis is an efficient strategy to counteract the development of type 2 diabetes. Hepatic glucose production into the bloodstream is controlled by the GLUT2 transporter and a vesicular pathway dependent on Caveolin-1 (CAV1) involving G6PC1 location at the plasma membrane. We hypothesized that decreasing hepatic gluconeogenesis by targeting CAV1 specifically in the liver (L.Cav1-/- mice) improves energy and glucose metabolism in diabetic mice. Here we show that the absence of hepatic CAV1 increases insulin sensitivity, glucose tolerance and decreases fasting hyperglycemia and hyperinsulinemia in mice feeding a high fat high sucrose diet (HFHS diet). The decrease in insulin sensitivity takes place also in L.Cav1-/- mice feeding a standard diet (STD diet). Moreover, we demonstrated an improvement of glycemic control when hepatic Cav1 is deleted in previously prediabetic mice. In parallel, the absence of CAV1 in the liver reduces body weight gain and lipid intestinal absorption. Together these findings highlight that the vesicular pathway of glucose production represents a promising therapeutic target in the prevention of type 2 diabetes.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Active integrins regulate white adipose tissue insulin sensitivity and brown fat thermogenesis 96%
- Antisense oligonucleotides against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1 96%
- Targeted and selective knockout of the TLQP-21 neuropeptide unmasks its unique role in energy homeostasis 95%
Similar papers in this journal
- β-cell SENP1 facilitates responsiveness to incretins and limits oral glucose intolerance in high fat fed mice 96%
- Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity 95%
- Increased energy expenditure and protection from diet-induced obesity in mice lacking the cGMP-specific phosphodiesterase, PDE9 95%
Similar papers in this journal
Similar papers in this journal
- ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity 96%
- Non-canonical Metabolic and Molecular Effects of Calorie Restriction Are Revealed by Varying Temporal Conditions 96%
- Integration of metabolomic and transcriptomic analyses reveals novel regulatory functions of the ChREBP transcription factor in energy metabolism 96%
Similar papers in this journal
- Neuropeptide Neuromedin B does not alter body weight and glucose homeostasis nor does it act as an insulin-releasing peptide 97%
- Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice 95%
- Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.